- FDA opens dialogue of incorporating technology, pharmacy into switch paradigm
- Report: Rxs for Viagra, Cialis get boost from Valentine's Day
- Report: Pfizer seeks aid of PBMs in efforts to block generic versions of Lipitor
- Watson seeks FDA approval for generic Welchol
- FDA approves Prevnar 13 in older adults
PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.
Watson said the FDA approved its sildenafil tablets in the 20 mg strength through a subsidiary. Watson said it would launch the drug "in the near future."
The drug is a generic version of Pfizer's Revatio tablets, which had sales of about $339 million during the 12-month period ended in September, according to IMS Health.